Inactief instrument

Koers Tobira Therapeutics Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

TOBIRA fait gagner plus de 40 000 euros à un investisseur !	26-10-16
Tobira Therapeutics : Announces Late-Breaking Oral Presentation of CENTAUR Phase 2b Trial Results at the American Academy for the Study of Liver Diseases Annual Meeting	20-10-16
Tobira Therapeutics : Announces Presentations Related to Cenicriviroc’s Development Program in NASH at the American Academy for the Study of Liver Diseases Annual Meeting	03-10-16
TBRA Brower Piven Commences An Investigation Into The Proposed Sale Of Tobira Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	21-09-16
Tobira Therapeutics : Allergan to Acquire Tobira Therapeutics Expanding Global GI R&D Pipeline and Taking a Leading R&D Position in NASH	20-09-16

Managers	Titel	Leeftijd	Van
Robert Michael CEO	Chief Executive Officer	53	-
Scott Reents DFI	Director of Finance/CFO	57	-
Jennifer M. Lagunas SEC	Corporate Secretary	-	-

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 mld.
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 mld.
ARGENX SE	+1,69%	22,15 mld.
BIONTECH SE	-17,37%	21,02 mld.
GENMAB A/S	-9,30%	18,15 mld.
WUXI APPTEC CO., LTD.	-41,01%	16,74 mld.
BEIGENE, LTD.	-14,85%	16,05 mld.
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 mld.
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 mld.